BLENOXANE (BLEOMYCIN SULFATE) — FDA Approval NDA050443 (BRISTOL MYERS SQUIBB)
BLENOXANE (BLEOMYCIN SULFATE) — FDA Approval NDA050443 (BRISTOL MYERS SQUIBB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BLENOXANE; Active ingredients: BLEOMYCIN SULFATE; Application number: NDA050443.
| Brand name | BLENOXANE |
|---|---|
| Active ingredients | BLEOMYCIN SULFATE |
| Application number | NDA050443 |
| Sponsor | BRISTOL MYERS SQUIBB |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19730731 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →